- Home
- MPX vs MNPR Comparison
MPX vs MNPR Comparison
Compare MPX & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPX
- MNPR
- Stock Information
- Founded
- MPX 1965
- MNPR 2014
- Country
- MPX United States
- MNPR United States
- Employees
- MPX N/A
- MNPR N/A
- Industry
- MPX Marine Transportation
- MNPR Biotechnology: Pharmaceutical Preparations
- Sector
- MPX Industrials
- MNPR Health Care
- Exchange
- MPX Nasdaq
- MNPR Nasdaq
- Market Cap
- MPX 297.8M
- MNPR 249.5M
- IPO Year
- MPX N/A
- MNPR 2019
- Fundamental
- Price
- MPX $8.14
- MNPR $38.02
- Analyst Decision
- MPX Hold
- MNPR Strong Buy
- Analyst Count
- MPX 1
- MNPR 5
- Target Price
- MPX $8.00
- MNPR $59.50
- AVG Volume (30 Days)
- MPX 21.8K
- MNPR 24.1K
- Earning Date
- MPX 07-24-2025
- MNPR 05-13-2025
- Dividend Yield
- MPX 6.90%
- MNPR N/A
- EPS Growth
- MPX N/A
- MNPR N/A
- EPS
- MPX 0.43
- MNPR N/A
- Revenue
- MPX $226,217,000.00
- MNPR N/A
- Revenue This Year
- MPX $3.97
- MNPR N/A
- Revenue Next Year
- MPX $13.02
- MNPR N/A
- P/E Ratio
- MPX $19.09
- MNPR N/A
- Revenue Growth
- MPX N/A
- MNPR N/A
- 52 Week Low
- MPX $7.49
- MNPR $1.72
- 52 Week High
- MPX $10.89
- MNPR $54.30
- Technical
- Relative Strength Index (RSI)
- MPX 42.01
- MNPR 54.49
- Support Level
- MPX $8.02
- MNPR $28.40
- Resistance Level
- MPX $8.45
- MNPR $36.82
- Average True Range (ATR)
- MPX 0.26
- MNPR 3.16
- MACD
- MPX -0.05
- MNPR 0.10
- Stochastic Oscillator
- MPX 22.58
- MNPR 80.60
About MPX Marine Products Corporation
Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the powerboat manufacturing business segment in Nashville, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats, and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.